phosphotyrosine has been researched along with Liver Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, S; Gao, B; Hong, F; Jaruga, B; Kim, WH; Radaeva, S | 1 |
Iwamura, K; Noguchi, K; Ogawa, R; Ohtsuka, M; Watanabe, Y | 1 |
2 other study(ies) available for phosphotyrosine and Liver Diseases
Article | Year |
---|---|
STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.
Topics: Animals; Apoptosis; Cell Line; Chemical and Drug Induced Liver Injury; DNA Fragmentation; DNA-Binding Proteins; Flow Cytometry; Galactosamine; Hepatocytes; Interferon-gamma; Lipopolysaccharides; Liver Diseases; Mice; Mice, Inbred BALB C; Mice, Knockout; Phosphorylation; Phosphotyrosine; STAT1 Transcription Factor; Trans-Activators; Transfection; Tumor Necrosis Factor-alpha | 2003 |
Anti-O-phosphotyrosine antibodies in human sera.
Topics: Adolescent; Adult; Aged; Antibodies; Antibody Affinity; Child; Child, Preschool; Collagen Diseases; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infant; Infant, Newborn; Liver Diseases; Lung Diseases; Male; Middle Aged; Neoplasms; Nervous System Diseases; Phosphotyrosine; Tyrosine | 1985 |